These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 4179302)

  • 1. Serum luteinizing and follicle stimulating hormone levels during sequential and nonsequential contraceptive treatment of eugonadal women.
    Swerdloff RS; Odell WD
    J Clin Endocrinol Metab; 1969 Feb; 29(2):157-63. PubMed ID: 4179302
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral contraceptives and follicle-stimulating hormone.
    Cargille CM; Ross GT
    Lancet; 1968 Apr; 1(7548):924. PubMed ID: 4171528
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on the site of action of oral contraceptive steroids. II. Plasma LH and FSH levels after administration of antifertility steroids and LH-releasing hormone(LH-RH).
    Schally AV; Parlow AF; Carter WH; Saito M; Bowers CY; Arimura A
    Endocrinology; 1970 Mar; 86(3):530-41. PubMed ID: 4188612
    [No Abstract]   [Full Text] [Related]  

  • 4. Endocrine properties and mechanism of action of oral contraceptives.
    Saunders FJ
    Fed Proc; 1970; 29(3):1211-9. PubMed ID: 4910270
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the site of action of oral contraceptive steroids. I. Effect of antifertility steroids on plasma LH levels and on the response to luteinizing hormone-releasing factor in rats.
    Schally AV; Carter WH; Saito M; Arimura A; Bowers CY
    J Clin Endocrinol Metab; 1968 Dec; 28(12):1747-55. PubMed ID: 4177382
    [No Abstract]   [Full Text] [Related]  

  • 6. [Plasma levels of FSH and LH during the menstrual cycle, the menopause and in the course of gestagen treatment].
    Czygan PJ
    Acta Endocrinol Suppl (Copenh); 1971; 152():2. PubMed ID: 4101326
    [No Abstract]   [Full Text] [Related]  

  • 7. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
    Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
    J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological inhibition and stimulation of ovulation].
    Tausk M
    Wien Klin Wochenschr; 1968 Jul; 80(29):561-7. PubMed ID: 4303154
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of a combination of norethynodrel and mestranol on plasma luteinizing hormone in normal women.
    Abraham GE; Klaiber EL; Broverman D
    Am J Obstet Gynecol; 1969 Aug; 104(7):1038-42. PubMed ID: 5794834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential approach to oral contraceptive therapy.
    Balin H; Wan LS; Rajan R
    Int J Fertil; 1969; 14(4):300-8. PubMed ID: 4186408
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of contraceptive hormone preparations on the fine structure of the endometrium.
    Friedrich ER
    Obstet Gynecol; 1967 Aug; 30(2):201-19. PubMed ID: 4143586
    [No Abstract]   [Full Text] [Related]  

  • 12. Feedback control of pituitary gonadotropins.
    Odell WD; Swerdloff RS
    Adv Biosci; 1975; 15():141-62. PubMed ID: 51805
    [No Abstract]   [Full Text] [Related]  

  • 13. [Action of a contraceptive steroid on the hypothalamo-neurohypophyseal neurosecretory pathway in white rats].
    Gabe M; Schramm B; Tuchmann-Duplessis H
    C R Seances Soc Biol Fil; 1968; 162(2):375-81. PubMed ID: 4236613
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ovulation inhibitors and oral contraceptive agents. 3].
    Albrecht JH
    Pharm Prax; 1967; 5():115-23. PubMed ID: 4179423
    [No Abstract]   [Full Text] [Related]  

  • 15. [Gonadotropin secretion in man].
    Franchimont P
    Munch Med Wochenschr; 1970 Dec; 112(51):2303-12. PubMed ID: 5537017
    [No Abstract]   [Full Text] [Related]  

  • 16. [Serum prolactin and gonadotropins during the normal menstrual cycle and during oral contraceptives].
    Vekemans M; L'Hermite M; Robyn C
    J Gynecol Obstet Biol Reprod (Paris); 1972; 1(5 Suppl 2):354-6. PubMed ID: 4143445
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of oral contraceptive steroids on jejunal pyruvate kinase and adenyl cyclase activities.
    Stifel FB; Greene HL; Herman RH
    Endocrinology; 1971 Sep; 89(3):896-7. PubMed ID: 4105307
    [No Abstract]   [Full Text] [Related]  

  • 18. Concentration of luteinizing and follicle-stimulating hormones in peripheral and ovarian venous plasma.
    Llerena LA; Guevara A; Lobotsky J; Lloyd CW; Weisz J; Pupkin M; Zanartu J; Puga J
    J Clin Endocrinol Metab; 1969 Aug; 29(8):1083-9. PubMed ID: 4184697
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of the long term administration of oral contraceptives on excretion values for follicle-stimulating hormone and luteinising hormone.
    Bell ET; Herbst AL; Krishnamurti M; Loraine JA; Mears E; Jackson MC; Garcia CR
    Acta Endocrinol (Copenh); 1967 Jan; 54(1):96-104. PubMed ID: 6071215
    [No Abstract]   [Full Text] [Related]  

  • 20. Electroencephalographic changes in women treated with contraceptive steroids.
    Gautray JP; Eberhard A; Jalivet A; Leygonie G
    Basic Life Sci; 1974; 4(PART A):385-97. PubMed ID: 4447577
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.